文献速递乳腺US

基于自动乳腺容积扫描仪的瘤内及瘤周影像组学列线图用于术前预测乳腺恶性肿瘤中Ki-67的表达

An Automated Breast Volume Scanner-Based Intra- and Peritumoral Radiomics Nomogram for the Preoperative Prediction of Expression of Ki-67 in Breast Malignancy.
PubMed 文献 · Acad Radiol · 2023-08-04

本研究回顾性纳入197例乳腺恶性肿瘤患者,以14%为阈值将Ki-67表达分为低表达和高表达两组,基于瘤内及瘤周10 mm感兴趣区的1702个影像组学特征构建影像组学标签,并结合肿瘤大小和超声报告的淋巴结状态建立列线图。列线图在训练队列中特异度0.944、敏感度0.745、AUC 0.905,在验证队列中特异度0.909、敏感度0.727、AUC 0.882,决策曲线分析显示其具有临床实用性,校准曲线显示预期值与检测值高度一致。

要点

  • 列线图整合肿瘤大小、影像组学标签和超声报告的淋巴结状态三个独立预测因子。
  • 训练队列特异度0.944、敏感度0.745、AUC 0.905;验证队列特异度0.909、敏感度0.727、AUC 0.882。
  • Ki-67表达以14%为阈值分为低表达和高表达两组。

核心结论

  • 该列线图可准确预测乳腺恶性肿瘤患者的Ki-67表达,有助于制定个性化治疗方案。

研究设计与样本

  • 回顾性研究,纳入197例经本院收治的乳腺恶性肿瘤患者,基于瘤内及瘤周10 mm感兴趣区的1702个影像组学特征构建影像组学标签,采用多变量逻辑回归结合影像组学标签和超声特征建立列线图,以14%为阈值将Ki-67表达分为低表达和高表达两组。

诊断标准与关键数值

  • 列线图包含三个独立预测因子:肿瘤大小(P = .037)、影像组学标签(P < .001)和超声报告的淋巴结状态(P = .018);训练队列特异度0.944、敏感度0.745、AUC 0.905;验证队列特异度0.909、敏感度0.727、AUC 0.882。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aimed to create and verify a nomogram for preoperative prediction of Ki-67 expression in breast malignancy to assist in the development of personalized treatment strategies.

MATERIALS AND METHODS: This retrospective study received approval from the institutional review board and included a cohort of 197 patients with breast malignancy who were admitted to our hospital. Ki-67 expression was divided into two groups based on a 14% threshold: low and high. A radiomics signature was built utilizing 1702 radiomics features based on an intra- and peritumoral (10 mm) regions of interest. Using multivariate logistic regression, radiomics signature, and ultrasound (US) characteristics, the nomogram was developed. To evaluate the model's calibration, clinical application, and predictive ability, decision curve analysis (DCA), the calibration curve, and the receiver operating characteristic curve were used, respectively.

RESULTS: The final nomogram included three independent predictors: tumor size (P = .037), radiomics signature (P < .001), and US-reported lymph node status (P = .018). The nomogram exhibited satisfactory performance in the training cohort, demonstrating a specificity of 0.944, a sensitivity of 0.745, and an area under the curve (AUC) of 0.905. The validation cohort recorded a specificity of 0.909, a sensitivity of 0.727, and an AUC of 0.882. The DCA showed the nomogram's clinical utility, and the calibration curve revealed a high consistency among the expected and detected values.

CONCLUSION: The nomogram used in this investigation can accurately predict Ki-67 expression in people with malignant breast tumors, helping to develop personalized treatment approaches.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Wu Y, Ma Q, Fan L, et al. An Automated Breast Volume Scanner-Based Intra- and Peritumoral Radiomics Nomogram for the Preoperative Prediction of Expression of Ki-67 in Breast Malignancy. Acad Radiol. 2023. PMID: 37544789. doi:10.1016/j.acra.2023.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。